Active Ingredient History

NOW
  • Now
Sotagliflozin, sold under the brand name Zynquista, is a drug approved in the European Union for people with type 1 diabetes.   Wikipedia

  • SMILES: CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)cc1
  • InChIKey: QKDRXGFQVGOQKS-CRSSMBPESA-N
  • Mol. Mass: 424.95
  • ALogP: 3.17
  • ChEMBL Molecule:
More Chemistry
(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol | lp-802034 | lx4211 | lx-4211 | sotagliflozin

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue